Today: 30 April 2026
Browse Category

Stock Market 30 December 2025

MongoDB stock today: MDB slips as “MongoBleed” vulnerability and patch push stay in focus

MongoDB stock today: MDB slips as “MongoBleed” vulnerability and patch push stay in focus

MongoDB shares slipped 0.3% to $422.06 Tuesday after U.S. officials added the “MongoBleed” CVE-2025-14847 flaw to a federal exploited-vulnerabilities list. The bug, affecting zlib-compressed MongoDB servers, allows unauthenticated data access and has public exploit code. MongoDB said its Atlas cloud service is patched. Over 87,000 internet-exposed servers may be at risk, according to Tenable.
30 December 2025
···
Synopsys stock slips today as SNPS faces lawsuit deadline in thin year-end trade

Synopsys stock slips today as SNPS faces lawsuit deadline in thin year-end trade

Synopsys shares fell 0.6% to $475.91 in late-afternoon New York trading as investors eyed a Tuesday deadline to seek lead-plaintiff status in a securities class action. The stock tracked a muted tech sector, with Cadence down 0.4% and SOXX flat. The lawsuit alleges misleading statements about Synopsys’ Design IP business. Year-end liquidity remained thin ahead of the Fed minutes release.
30 December 2025
·
S&P Global (SPGI) stock slips near $529 as Fed minutes, year-end flows keep Wall Street muted

S&P Global (SPGI) stock slips near $529 as Fed minutes, year-end flows keep Wall Street muted

S&P Global shares slipped 0.16% to $529.25 Tuesday after its Mobility unit forecast a 2.5% drop in 2026 U.S. auto sales, citing affordability concerns. Moody’s and MSCI also traded lower. Major U.S. index ETFs hovered near flat in thin year-end trading. S&P Global Mobility projects 2026 U.S. light-vehicle sales at 15.89 million units, down from a projected 16.3 million for 2025.
30 December 2025
··
SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

Scholar Rock shares fell 3.2% to $43.76 Tuesday afternoon, underperforming biotech peers as investors watched for updates on FDA reinspection timing for its lead drug, apitegromab. The company aims to resubmit its biologics license application in 2026 after the Indiana fill-finish site, now owned by Novo Nordisk, completes remediation and is reinspected by year-end 2025.
30 December 2025
·
Progressive stock ticks higher today after SEC filing flags 87,755-share gift; what investors watch next

Progressive stock ticks higher today after SEC filing flags 87,755-share gift; what investors watch next

Progressive shares rose 0.7% to $230 Tuesday after a regulatory filing showed director Charles A. Davis donated 87,755 shares to a charitable foundation. The stock traded between $227.53 and $230.03 on volume of about 1 million shares. U.S. insurance stocks edged higher in thin year-end trading. Davis retained 250,222 shares after the transaction.
30 December 2025
···
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL shares dropped 3.3% to $84.95 Tuesday afternoon, extending a two-day slide. An Oregon Health & Science University release highlighted PATHFINDER 2 data and confirmed a first-quarter 2026 FDA submission for Galleri. Investors await management’s Jan. 12 update at the J.P. Morgan Healthcare Conference. The stock is down 7.2% since Friday’s close.
30 December 2025
··
Bloom Energy stock slips today as Clear Street lifts target but keeps Hold in thin year-end trade

Bloom Energy stock slips today as Clear Street lifts target but keeps Hold in thin year-end trade

Bloom Energy shares fell 1.7% to $86.93 in afternoon trading Tuesday, moving between $90.11 and $86.00 on light holiday volume. Clear Street raised its price target to $58 but kept a Hold rating, citing data-center capacity expectations. Bloom disclosed a new $600 million revolving credit facility led by Wells Fargo in a Dec. 23 SEC filing. Peers Plug Power and FuelCell Energy also declined.
30 December 2025
··
American Airlines stock edges up today as Chicago O’Hare expansion and storm fallout stay in focus

American Airlines stock edges up today as Chicago O’Hare expansion and storm fallout stay in focus

American Airlines shares rose 0.6% to $15.24 Tuesday after announcing 100 additional peak daily departures from Chicago O’Hare for spring. The carrier also plans to extend summer service to Paris and Dublin. Investors are watching for winter-storm impacts and fuel costs ahead of expected late-January results. Airline stocks had dropped Monday as Winter Storm Ezra disrupted travel.
30 December 2025
···
TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

TIC Solutions shares dropped 3.5% to $10.02 in thin year-end trading Tuesday, underperforming a steady U.S. market. The decline followed Federal Reserve minutes showing policy divisions and came as investors awaited January jobs and inflation data. Trading volume in TIC lagged its recent average, and peers Mistras Group and Jacobs Solutions slipped less than 1%.
30 December 2025
··
Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

Applied Materials shares fell 1.1% to $260.27 Tuesday after Reuters reported China now requires chipmakers expanding capacity to source at least 50% of equipment domestically. The iShares Semiconductor ETF was little changed. Wells Fargo raised its price target on Applied Materials to $290 and maintained an Overweight rating. Lam Research and KLA shares also slipped about 1%.
30 December 2025
·····
Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals shares fell 3% to $23.33 in thin afternoon trading Tuesday, extending a two-day slide and leaving the stock about 12% below its June high. Biotech ETFs underperformed the broader market, with the iShares Nasdaq Biotechnology ETF down 1.2%. Investors are awaiting the Federal Reserve’s meeting minutes and Catalyst’s next update in January.
30 December 2025
··
1 … 759 760 761 762 763 … 1,402

Stock Market Today

  • Investors Favor Google's AI Spending Over Meta Despite Both Raising Capex Guidance
    April 29, 2026, 10:00 PM EDT. Alphabet and Meta both reported strong first-quarter earnings, raising capital expenditure (capex) forecasts to fuel AI infrastructure. Alphabet's shares jumped 7% post-earnings, while Meta's dropped 7%, reflecting investor trust in Google's AI strategy. Alphabet's cloud division grew 63%, bolstering revenue by 20%, with a capex guidance raised to $180-$190 billion through 2026. Meta increased its capex forecast to $125-$145 billion, citing component costs and data center investments. Wall Street favors Alphabet's cloud-driven AI growth, contrasting with skepticism over Meta's AI investments tied primarily to advertising. Alphabet's stock is up 118% over the past year compared to Meta's 21%, underscoring the market's preference for sustainable AI revenue models.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop